CRO's Cross Over NOW

The digital revolution is knocking at the doors of the clinical research industry, and CROs are increasingly, if reluctantly, letting it in. Although the biotech industry revels in the promise of wireless solutions, Internet applications, and genomic discoveries, CROs have largely shunned opportunities for technological improvements and remain insulated from such advances in other health sectors.

Related Content:

Pharmaceutical Executive-07-01-2001

Amgen's New Dream Team

Pharmacies: OTC Price Wars

One Disease at a Time